4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000147
Chairperson & CEO sold 9,500 shares at an average $494.83 ($4,700,851)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-22 | Sale : show line 2 in the form 10b5-1 | −240 | $489.61 | $117,507 | 333,703 | I |
| 2026-09-22 | Sale : show line 3 in the form 10b5-1 | −424 | $490.54 | $207,988 | 333,279 | I |
| 2026-09-22 | Sale : show line 4 in the form 10b5-1 | −736 | $491.45 | $361,705 | 332,543 | I |
| 2026-09-22 | Sale : show line 5 in the form 10b5-1 | −628 | $492.67 | $309,395 | 331,915 | I |
| 2026-09-22 | Sale : show line 6 in the form 10b5-1 | −1,645 | $493.70 | $812,139 | 330,270 | I |
| 2026-09-22 | Sale : show line 7 in the form 10b5-1 | −1,337 | $494.66 | $661,358 | 328,933 | I |
| 2026-09-22 | Sale : show line 8 in the form 10b5-1 | −1,488 | $495.77 | $737,700 | 327,445 | I |
| Open-market sales · 9,500 sh · avg $494.83 · $4,700,851 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-22 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option | −9,500 | 385,410 | I |
Loading xslF345X06/primarydocument.xml…